Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7603783 | 0.89 | KMT2A (0.38) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL261875 | 0.86 | KDM4E (0.40) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL262414 | 0.86 | KDM4E (0.40) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL7600820 | 0.81 | KDM4E (0.43) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL7602348 | 0.81 | KDM4E (0.41) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL25137923 | 0.80 | KDM4E (0.46) | KDM4EATML3MBTL1ALDH1A1HPGD | |
| SCHEMBL14029386 | 0.80 | TSPO (0.39) | KDM4EKMT2AALDH1A1RCE1TSPO | |
| SCHEMBL10098586 | 0.79 | KDM4E (0.46) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL10098620 | 0.78 | KDM4E (0.45) | KDM4EATML3MBTL1KMT2AALDH1A1 | |
| SCHEMBL262412 | 0.78 | KDM4E (0.45) | KDM4EATML3MBTL1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183793-B2 | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-8183793-B2 | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| WO-2008026614-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | ALAD, CYP2C9, CYP1A1 | KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885 |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | ALAD, CYP2C9, CYP1A1 | KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.